[go: up one dir, main page]

WO2007079386A3 - Method of diagnosing a body weight condition or predisposition in an animal - Google Patents

Method of diagnosing a body weight condition or predisposition in an animal Download PDF

Info

Publication number
WO2007079386A3
WO2007079386A3 PCT/US2006/062640 US2006062640W WO2007079386A3 WO 2007079386 A3 WO2007079386 A3 WO 2007079386A3 US 2006062640 W US2006062640 W US 2006062640W WO 2007079386 A3 WO2007079386 A3 WO 2007079386A3
Authority
WO
WIPO (PCT)
Prior art keywords
body weight
predisposition
animal
weight condition
diagnosing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/062640
Other languages
French (fr)
Other versions
WO2007079386A2 (en
Inventor
William D Schoenherr
Cheryl C Miller
Kim G Friesen
Philip W Toll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hills Pet Nutrition Inc
Original Assignee
Hills Pet Nutrition Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hills Pet Nutrition Inc filed Critical Hills Pet Nutrition Inc
Publication of WO2007079386A2 publication Critical patent/WO2007079386A2/en
Publication of WO2007079386A3 publication Critical patent/WO2007079386A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/04—Endocrine or metabolic disorders
    • G01N2800/044—Hyperlipemia or hypolipemia, e.g. dyslipidaemia, obesity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

A method for diagnosing a body weight condition or predisposition to a body weight condition in an animal by determining observed level(s) of at least one biomarker in a tissue or biofluid sample from the animal, and comparing the observed level(s) to reference level(s) for the biomarker: wherein the observed level(s) relative to the reference level(s) are individually or collectively indicative of the body weight condition or predisposition.
PCT/US2006/062640 2005-12-28 2006-12-28 Method of diagnosing a body weight condition or predisposition in an animal Ceased WO2007079386A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US75448205P 2005-12-28 2005-12-28
US60/754,482 2005-12-28

Publications (2)

Publication Number Publication Date
WO2007079386A2 WO2007079386A2 (en) 2007-07-12
WO2007079386A3 true WO2007079386A3 (en) 2007-10-25

Family

ID=38171267

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/062640 Ceased WO2007079386A2 (en) 2005-12-28 2006-12-28 Method of diagnosing a body weight condition or predisposition in an animal

Country Status (2)

Country Link
CN (1) CN101427134A (en)
WO (1) WO2007079386A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2569698C2 (en) * 2010-01-06 2015-11-27 Хилл`С Пет Ньютришн, Инк. Method for animal's body mass management
MX387567B (en) * 2015-08-11 2025-03-18 Soc Des Produits Nestle S A Star METHODS USING MORPHOMETRIC MEASUREMENTS OF A SMALL DOG TO IMPROVE FOOD FOR SMALL DOGS.

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233393A1 (en) * 2004-02-27 2005-10-20 Wynne-Edwards Katherine E Dynamic hormone index as a biomarker for disease
WO2006063213A2 (en) * 2004-12-10 2006-06-15 University Of Maryland, Baltimore Serum amyloid a protein in inflammation and obesity

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050233393A1 (en) * 2004-02-27 2005-10-20 Wynne-Edwards Katherine E Dynamic hormone index as a biomarker for disease
WO2006063213A2 (en) * 2004-12-10 2006-06-15 University Of Maryland, Baltimore Serum amyloid a protein in inflammation and obesity

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
APPLETON D J ET AL: "Plasma leptin concentrations in cats: reference range, effect of weight gain and relationship with adiposity as measured by dual energy X-ray absorptiometry.", JOURNAL OF FELINE MEDICINE AND SURGERY DEC 2000, vol. 2, no. 4, December 2000 (2000-12-01), pages 191 - 199, XP009087672, ISSN: 1098-612X *
DAMINET S ET AL: "Evaluation of thyroid function in obese dogs and in dogs undergoing a weight loss protocol.", JOURNAL OF VETERINARY MEDICINE SERIES A, vol. 50, no. 4, May 2003 (2003-05-01), pages 213 - 218, XP002445146, ISSN: 0931-184X *
JEUSETTE ISABELLE C ET AL: "Influence of obesity on plasma lipid and lipoprotein concentrations in dogs", AMERICAN JOURNAL OF VETERINARY RESEARCH, vol. 66, no. 1, January 2005 (2005-01-01), pages 81 - 86, XP009086366, ISSN: 0002-9645 *
KIRK C A ET AL: "Diagnosis of naturally acquired type-I and type-II diabetes mellitus in cats", AMERICAN JOURNAL OF VETERINARY RESEARCH, vol. 54, no. 3, 1993, pages 463 - 467, XP009087685, ISSN: 0002-9645 *
SAGAWA MAYUMI M ET AL: "Correlation between plasma leptin concentration and body fat content in dogs", AMERICAN JOURNAL OF VETERINARY RESEARCH, XX, XX, vol. 63, no. 1, January 2002 (2002-01-01), pages 7 - 10, XP009086365, ISSN: 0002-9645 *

Also Published As

Publication number Publication date
CN101427134A (en) 2009-05-06
WO2007079386A2 (en) 2007-07-12

Similar Documents

Publication Publication Date Title
WO2007103374A3 (en) Toxicity screening methods
EP2804001A3 (en) Methods for diagnosing prostate carcinomas
WO2005114190A3 (en) Methods of identifying biomarkers
WO2012018535A3 (en) Wellness panel
WO2005077007A3 (en) Methods of diagnosing and treating pre-eclampsia or eclampsia
WO2006089091A3 (en) Methods for detecting minimum residual disease
WO2007147076A3 (en) Methods for the diagnosis of fetal abnormalities
EP2813848A3 (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2008030979A3 (en) Methods of screening for gastrointestinal cancer
WO2007103116A3 (en) Methods and systems for evaluating health risk factors by measurement of dna damage and dna repair
WO2004096985A3 (en) Methods for assessing biologic diversity
WO2008134596A3 (en) Use of methylated or unmethylated line-i dna as a cancer marker
WO2010028373A3 (en) Methods for diagnosing cancer and determining the overall survival and disease-free survival of cancer patients
WO2008129296A3 (en) Disease markers
WO2008033427A3 (en) Compositions and methods for detection of lysosomal storage disease
WO2006113245A3 (en) Methods for measuring glycan levels of proteins
WO2007134028A3 (en) Biomarkers for depression and methods using the same
WO2006015387A3 (en) Method for assaying cytolytic activity of target cells
WO2007079301A3 (en) Method of diagnosing a body weight condition or predisposition in an animal
EP2557421A3 (en) Altered mitochondrial activity in diseases resulting from oxidative stress
WO2007030949A3 (en) Methods of diagnosing ovarian cancer and kits therefor
WO2010144553A3 (en) Methods for diagnosing blood vessel reocclusion
WO2010035259A3 (en) Compositions comprising soluble cd84 or anti-cd84 antibodies and methods for diagnosing and treating b-cll
EP2415877A3 (en) Means and methods for diagnosing pancreatic cancer
WO2009133197A3 (en) Levels of april in serum and use in diagnostic methods

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06848468

Country of ref document: EP

Kind code of ref document: A2